This post discusses the essential incentives that motivate inventors, including recognition, supportive work environments, personnel policies, and financial rewards. It emphasises the importance of a balanced, well-designed mechanism tailored to organisational goals and sector-specific requirements.
Read more about How Can We Encourage Inventors to Invent?Category: Patents
Model to Combat Patent Risks in Open Source Software
The defensive patent license model offers a structured approach to reduce patent risks in open source software. While it faces implementation and philosophical challenges, it remains a significant initiative for the open source community seeking to mitigate litigation threats.
Read more about Model to Combat Patent Risks in Open Source SoftwareIndian Patent Statistics, Interesting inventions, Vice President M. Venkaiah Naidu speaks on patents, IPR course by VTU, Patent infringement disputes and more
The post provides a comprehensive update on Indian patent statistics, recent patent grants, and notable inventions. It also covers key legal developments, including recent patent infringement disputes and new educational initiatives in intellectual property rights.
Read more about Indian Patent Statistics, Interesting inventions, Vice President M. Venkaiah Naidu speaks on patents, IPR course by VTU, Patent infringement disputes and morePatent Law – Rationale and Life Cycle – A Presentation by Dr. Kalyan C. Kankanala at NLS – Bangalore
[slideshare id=123861315&doc=patentlawrationaleandlifecycle-181124123014]
Read more about Patent Law – Rationale and Life Cycle – A Presentation by Dr. Kalyan C. Kankanala at NLS – BangalorePatentability requirements – A Presentation by Dr. Kalyan C. Kankanala at NLS – Bangalore
[slideshare id=123861782&doc=patentabilityinindia-181124124503]
Read more about Patentability requirements – A Presentation by Dr. Kalyan C. Kankanala at NLS – BangaloreNew patent policy in India? Interesting Patents, L’Oréal vesrus Drunk Elephant, No patent settlement talks for Qualcomm and Apple, No patent for Pfizer’s Pregablin says Supreme Court and more
The post presents a comprehensive overview of recent patent policy changes, key legal disputes, and statistical trends in India. It also covers prominent international IP events and critical judicial decisions impacting the patent landscape.
Read more about New patent policy in India? Interesting Patents, L’Oréal vesrus Drunk Elephant, No patent settlement talks for Qualcomm and Apple, No patent for Pfizer’s Pregablin says Supreme Court and moreInteresting Patents, IIT-M to host Tech summit, Cannabis Patent, Qualcomm forced to license its patents, Canada becomes party to Hague Agreement, USPTO’s new Sponsorship Tool and more
This update reviews Indian patent statistics, significant inventions, and key legal news in intellectual property. Highlights include the IIT Madras tech summit, Qualcomm’s licensing directive, cannabis patent developments, and Canada joining the Hague Agreement. The post provides a concise overview of national and international IP updates.
Read more about Interesting Patents, IIT-M to host Tech summit, Cannabis Patent, Qualcomm forced to license its patents, Canada becomes party to Hague Agreement, USPTO’s new Sponsorship Tool and moreRejection of Application Based on Pre-Grant Representation May Be Appealed to IPAB
The Delhi High Court has clarified that appeals to the IPAB are permitted when a patent application is rejected based on pre-grant representation. This judgment offers clear recourse for patent applicants and settles the legal position on such appeals under Indian patent law.
Read more about Rejection of Application Based on Pre-Grant Representation May Be Appealed to IPABWhat Should I do With My Invention Before I Talk to Venture Capitalists?
The article examines how inventors can protect their inventions before approaching venture capitalists, weighing the effectiveness of NDAs versus patent filings. It highlights the steps for obtaining a patentability opinion, conducting searches, and filing a patent application in India.
Read more about What Should I do With My Invention Before I Talk to Venture Capitalists?Pharmaceutical Business Strategy – A Brand Name Perspective
The post explores how brand name drug companies exploit regulatory provisions to maintain market dominance during generic drug challenges. It details the legal and procedural mechanisms involved, focusing on the strategic use of the 30 month stay period under the Hatch Waxman Act.
Read more about Pharmaceutical Business Strategy – A Brand Name Perspective